Literature DB >> 918842

Treatment of pars planitis II. corticosteroids.

T F Schlaegel, J C Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 918842     DOI： 10.1016/0039-6257(77)90093-5

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN： 0039-6257            Impact factor:   6.048


× No keyword cloud information.
  5 in total

1.  Prospective optical coherence tomographic evaluation of the efficacy of oral and posterior subtenon corticosteroids in patients with intermediate uveitis.

Authors:  Pradeep Venkatesh; Zaheer Abhas; Satpal Garg; Rajpal Vohra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-02       Impact factor: 3.117

2.  Clinical and immunopathological studies of pars planitis in a family.

Authors:  R P Wetzig; C C Chan; R B Nussenblatt; A G Palestine; D O Mazur; K K Mittal
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

3.  Endogenous uveitis in children.

Authors:  J C Merritt
Journal:  J Natl Med Assoc       Date:  1979-07       Impact factor: 1.798

4.  Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone.

Authors:  Kazuyuki Hirooka; Fumio Shiraga; Shigeto Tanaka; Tetsuya Baba; Hiroshi Mandai
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

5.  Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan.

Authors:  Yuki Maeda; Hiroto Ishikawa; Hiroki Nishikawa; Miho Shimizu; Takamasa Kinoshita; Rie Ogihara; Shigehiko Kitano; Chihiro Yamanaka; Yoshinori Mitamura; Masahiko Sugimoto; Mineo Kondo; Yoshihiro Takamura; Nahoko Ogata; Tomohiro Ikeda; Fumi Gomi
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.